Bhiman JN, Serwanga J, Ugwu CA, Vigan-Womas I, Quashie PK, Bhattacharya J, Sande C, Bonomo A, Markey FB, Awandare GA, Garg PK, Kaleebu P, Happi C, Rennergarbe A, Woods C, Kirchner J, Aguilar AO, Makar K, Moore PL
Trends Microbiol. 2025;
The Global Immunology and Immune Sequencing for Epidemic Response (GIISER) network, established in 2021, exemplifies the power of South-South collaboration in pandemic preparedness and response. Emerging from the COVID-19 crisis, GIISER integrated genomic surveillance, immunology, and capacity building across African, Asian, and South American sites, enabling rapid detection and characterization of SARS-CoV-2 variants. Through technology transfer, standardized protocols, and coordinated training, GIISER informed public health policy, advanced monoclonal antibody discovery, and strengthened local expertise. As COVID-19 research subsides and in the context of profound funding constraints, GIISER's scientific successes highlight the urgent need to sustain and expand regional networks to address current and future infectious disease threats, while championing diversity and scientific leadership in low- and middle-income countries (LMICs).
